Long-Term Efficacy and Complications of Radiofrequency Thermocoagulation at Different Temperatures for the Treatment of Trigeminal Neuralgia

Hong, Tao; Ding, Yuanyuan; Yao, Peng

doi:https://doi.org/10.1155/2020/3854284

Biochemistry Research International

On this page

Abstract Introduction Conclusion Conflicts of Interest Authors’ Contributions Acknowledgments References Copyright Related Articles

Review Article | Open Access

Volume 2020 | Article ID 3854284 | https://doi.org/10.1155/2020/3854284

Long-Term Efficacy and Complications of Radiofrequency Thermocoagulation at Different Temperatures for the Treatment of Trigeminal Neuralgia

Tao Hong,¹Yuanyuan Ding,¹and Peng Yao¹

Academic Editor: Robert J. Linhardt

Received26 Oct 2019

Revised30 Jan 2020

Accepted07 Feb 2020

Published05 Mar 2020

Abstract

Trigeminal neuralgia (TN) is a common neuropathic pain that seriously affects the daily life of patients. Many invasive treatments are currently available for patients who respond poorly to oral carbamazepine or oxcarbazepine. Among them, radiofrequency (RF) treatment is a viable option with reliable initial and long-term clinical efficacy. The long-term analgesic effects of radiofrequency thermocoagulation (RFT) at high temperatures (≥80°C) are not superior to those at relatively low temperatures (60–75°C). In contrast, the higher the temperature, the greater the risk of complications, especially facial numbness, masticatory muscles weakness, and corneal hypoesthesia. Some patients even experience irreversible lethal complications. Therefore, we recommend low-temperature RFT (60–75°C) for treatment of TN. The therapeutic effects of pulsed radiofrequency (PRF) are controversial, whereas PRF (≤75°C) combined with RFT can improve long-term effects and decrease the incidence of complications. However, large-scale clinical trials are needed to verify the efficacy of the combination of PRF and RFT.

1. Introduction

Trigeminal neuralgia (TN) is a common neuropathic pain disorder with symptoms of transient, electric-shock-like pain affecting one or more branches of the trigeminal nerve. Talking, eating, brushing teeth, and slight touching of trigger point located in the oral or perioral region can induce severe and brief pain. Severe pain can affect the daily activities of patients. Those who experienced long-term pain often experience emotional changes, such as anxiety and depression. Epidemiological studies have shown that elderly women have a higher incidence than men (1.5–2.1 times more than men), and the annual prevalence of the disease is 12.6–28.9 cases per 10 million people [1–4]. Patients with severe TN who cannot be completely controlled by oral carbamazepine or oxcarbazepine or who are intolerant to the adverse effect of drugs can benefit from invasive surgery. Common surgical interventions include percutaneous balloon compression [5], microvascular decompression (MVD) [6], gamma knife radiosurgery [7], RFT [8, 9], PRF [10, 11], and intradermal and/or subcutaneous injections of Botox [12], intragasserian phenol glycerite [13], and peripheral alcohol [14].

Although there are some serious complications reported in prior studies [9, 15–20], RFT is still an effective treatment for TN that can instantly relieve pain in 90%–100% of cases [15, 17–19, 21–24]. Kanpolat et al. have observed 1561 patients who underwent single-procedure RFT [21]. The proportion of patients who were painless for 5 years and did not require oral medication was as high as 57.7%. By 15 years, 42.2% of patients still had no recurrence of pain. Fouad observed 312 patients with TN [25]. The rate of pain relief after 2 years of RFT was as high as 97.2%, and the rate of pain recurrence tracking to 8.8 years was only 7.6%. Tang et al. have observed 1161 patients who underwent RFT via the Hartel anterior approach, and the pain relief rate was as high as 52% after 11 years [9]. The purpose of this review is to summarize the different temperatures utilizing RFT treatment for TN. Thus, we hope to reveal the optimal temperature suitable in RFT operation with best outcome.

2. Principles of RF

The main principle of RF treatment of TN is blockage pain signal conduction by high temperature up to 90°C to destroy the nerve (RFT) or modulation of the nociceptive nerve function of trigeminal nerve with temperature not exceeding 42°C (PRF). Two sets of technology can reduce the transmission of peripheral stimuli to the central nervous system, thereby preventing the disastrous pain. Although the pathogenesis of idiopathic trigeminal neuralgia is not completely clear, most scholars tend to believe that TN was associated with arterial or venous vascular compression, strategically located at the root entry zone. They recommended that MVD was the gold standard treatment for refractory TN and did not consider RF treatment to be involved in this pathogen [26, 27]. Prior clinical reports indicated that MVD can achieve similar or better results than RFT of the gasserian ganglion or trigeminal rootlets [19, 28, 29]. However, RFT is an alternative treatment for patients with recurrent TN after MVD, and it achieved good pain relief condition [23]. Therefore, by interfering with the function of the trigeminal nerve or destroying the integrity of its anatomical structure, therapeutic effects can be achieved.

3. The Pain Relief Rate of RFT at Different Temperatures for TN Treatment

There is no specific standard for temperature selection in RFT. A review of the published English literature indicated that the temperature for RFT varied widely among studies (60°C to 95°C). The theoretical basis for choosing high-temperature RFT is the hypothesis that the recurrence rate of TN is correlated with the degree of postoperative sensory deficit [9, 22, 30]. In support of this possibility, Taha et al. [22] have reported that the recurrence rate within 4 years was 100% among patients with mild postoperative facial numbness, whereas the rate was only 10% over a period of 10 years among patients with dense hypalgesia. Notably, those with analgesia had the lowest recurrence rate within 15 years. In addition, previous animal experiments have reported that temperatures below 80°C can selectively damage the Aб and C unmyelinated nerve fibers without damaging the Aα and Aβ nerve fibers, thereby blocking pain transmission without affecting facial tactile sensation [31].

High-temperature RFT (≥75°C) often leads to serious complications, such as severe facial numbness (84.7–100%) [9, 25], ptosis (0.7%) [9], keratitis (1.94–4.9%) [16, 25], corneal ulcers (0.6–2.6%) [9, 21], diplopia (0.66%) [9], abducens nerve damage (0.66–0.8%) [15, 21], transient vision loss and blindness (0.86%) [15], mandibular deviation (4%) [15], masticatory muscle weakness (8–15.8%) [9, 16], hearing loss (0.4%) [9], cerebrospinal fluid leakage (0.17%) [9], and even death (1.8–4%) [9, 32]. Those complications would cause pain to patients and lead to disputes between doctors and patients. The pain relief rate of RFT at ≥80°C had no significant advantage over RFT at 60–75°C. Kosugi et al. have reported the use of RFT at 90°C for patients with pain at the V2 and/or V3 branch, which achieved 1- and 2-year painlessness rates of 40.5%–80.2% and 17.1%–54.9%, respectively [30]. Son et al. have reported that after using 80°C RFT to treat TN, the proportions of patients achieving BNI I and II within 38 months were 71% and 15.8%, respectively [33].

Some studies use the recurrence rate as an indicator to assess the efficiency of high-temperature RFT for TN. The percentage of patients with recurrent pain ranged from 7.8% to 42.7% with tracking from 11.6 to 15 years [15, 21]. However, there were some limitations to the studies. The studies did not provide a detailed definition of “pain relief” or specify whether the patients used medication to control pain after the procedure. In addition, they included patients with secondary trigeminal neuralgia (STN) who had received other invasive interventions without success. Nonetheless, high-temperature RFT was not superior to low-temperature RFT in terms of the long-term pain relief rate. Tang et al. have analyzed a total of 1161 patients retrospectively and divided them into 65–70°C, 75°C, and 80–85°C groups according to the temperature used in the procedure [9]. Notably, there was no significant difference in the long-term pain relief rate among the three groups, thus suggesting that a higher temperature for RFT would not further increase long-term pain relief, and a temperature >65°C can generate satisfactory analgesic effects.

To explore the optimal temperature for achieving efficacious treatment of RFT, we conducted a multicenter clinical observational study to evaluate the long-term efficacy of low-temperature RFT, including temperatures of 62°C, 65°C, 68°C, 70°C, and 75°C for RFT [16, 34]. Patients with STN or V1 division of TN were excluded, as well as those who did not respond to other invasive procedures. The probability of experiencing no pain and requiring no drugs (BNI I) was 94.2%, 98.3%, 98.8%, 98.4%, and 98.9% at discharge; 83.8%, 90.1%, 91.4%, 94.3%, and 94.4% at 1 year after the procedure; and 66.7%, 80.5%, 88.2%, 84.3%, and 87.9% at 3 years after the procedure. These data suggest that the pain relief rates at discharge were similar at temperatures from 62°C to 75°C. With a prolonged follow-up time, the pain relief rate in the 62°C and 65°C groups decreased more significantly than that in the 68–75°C groups. However, up to 5 years after procedure, 59% and 64.3% of patients were pain-free in the 62°C and 65°C groups, confirming that 62–65°C in RFT is an efficacious temperature. Yang et al. have achieved a satisfactory pain reduction rate with RFT at 60°C; the proportion of patients whose pain reduction was >90% during 3-month–3.6-year follow-up period was as high as 80%, thus further supporting the efficacy and feasibility of low-temperature RFT [35]. In long-term follow-up, patients in the 75°C group appeared to have higher pain-free rates than those in the 68°C and 70°C groups, but this difference was not statistically significant. Zhao et al. have also compared the effectiveness of RFT at 70°C and 75°C and have found no significant differences in the rates of excellent relief in the Kaplan–Meier actuarial curve [32].

In summary, no significant differences were observed in the rates of pain relief after RFT at ≥80°C and ≤75°C. The probability of excellent pain relief at temperatures of 60–65°C was inferior to that at 68–75°C, whereas the analgesic effects were similar at 70°C and 75°C in some studies. Hence, we recommend RFT at 68–75°C.

4. Occurrence of Adverse Effects at Different Temperatures for RFT

The most common adverse effects after RFT treatment include facial numbness, masseter muscle weakness, and decreased or absent corneal reflexes (see Table 1).

The short-term incidence of mild facial numbness after RFT treatment is reportedly 85%–100% [15, 20, 25, 32, 34, 36, 41, 42], and facial numbness gradually decreases or disappears completely within 1 month. Long-term moderate facial numbness (BNI III) mainly occurs at temperatures ≥65°C. More specifically, the incidence was 0.23%–3.19% in the 65–70°C group [36], 24.2% in the 75°C group [34], and 39.8%–97.4% in the ≥85°C group [9, 15]. Severe facial numbness (BNI IV) mainly occurs at temperatures ≥75°C, with an incidence of 3.2% at 75°C [34] and 5.3%–14.5% at ≥80°C [9, 17].

Masticatory muscle weakness is usually associated with damage to the V3 branch (motor nerve), which is most likely to occur at temperatures ≥65°C. The incidence rate is 0.22%–4.8% at ≤68°C [34, 36], with a recovery time of approximately 6 months, 7.1%–12% at 70°C [37, 42], and 25.81%–44.12% at 75°C [34], with a recovery time of more than 1 year. Case reports have described permanent masseter muscle weakness or dysfunction [25].

Anatomically, the V1 division of the TN is adjacent to the oculomotor nerve, trochlear nerve, and abducens nerve. When higher temperatures are used in RFT, the coagulum size due to the radiofrequency probe increases in both length and diameter [43], thus potentially damaging the nerves near TN and causing severe complications, such as ptosis, limited eye movement, diplopia, and corneal ulceration. Therefore, the temperatures associated with V1 division should be selected with caution. Several studies have observed the specific temperature delivered to the V1 division. The incidence of decreased corneal reflex has been found to be 3.57%–17.5% at temperatures of 62–68°C [34, 38]. However, there are no reports of the disappearance of corneal reflexes. When the V1 division combined with V2 or/and V3, a higher stepped temperature from 70°C to 85°C was delivered to the V2 or/and V3. Decreased corneal reflexes were observed in a greater proportion of individuals, at 15.69%–26.47% [20, 34, 38]. Moreover, ptosis, limited eye movement, diplopia, and corneal ulceration have been reported in the literature with temperatures of 70–90°C [9, 21, 23, 44].

In summary, the incidence of adverse effects gradually increases with increasing RFT temperature. As the observation time increases, the degree of these adverse effects gradually lessens, but the recovery times vary with the temperature used for RFT. The incidence and severity of complications are lower at temperatures <70°C, and the recovery time is within 6 months. Severe facial numbness, permanent masticatory atonia, and corneal hypoesthesia are associated with using temperatures at ≥70°C, and some patients had not recovered by the end of the 5-year follow-up. Notably, irreversible and severe complications have low occurrence rates at temperatures ≤65°C for RFT. The probability of complications at 75°C is three- to eightfold greater than that at 70°C. These data suggest that inappropriately increasing the temperature for RFT can damage not only the Aб and C unmyelinated nerve fibers but also the Aα and Aβ fibers in a nonselective manner, thereby inducing severe complications [31], such as abducens nerve injury, diplopia, and vision loss at 95°C [15], as well as diplopia, hearing loss, and ptosis at 85°C [9].

5. The Pain Relief Rate of RFT Combined with PRF for the Temperature of TN

The magnetic field generated by PRF plays a therapeutic role by modulating the release of immune inflammatory mediators or inhibiting C-fiber activation and synaptic transmission [45]. PRF is effective for the treatment of neuropathic pain. Therefore, some researchers believe that PRF can produce good analgesic effects [20, 32, 36, 39, 40, 46–49]. However, the effectiveness of PRF for the treatment of TN remains controversial. The painlessness rate of the treatment is 0%–85.7% for 6 months and 0%–78.6% for 2 years. Luo et al. have explored the causes of the poor effects of PRF and have found that a higher output voltage and electrical field intensity result in better outcomes [50]. Chua et al. have suggested that shortening the pulsed width to 10 ms, enhancing the frequency to 4 Hz, and prolonging the treatment duration to 6 min can improve the long-term analgesic effect, at least to some extent [51].

RFT combined with PRF is a relatively new method for the treatment of TN, especially for the V1 branch. This procedure (RFT at 62–75°C combined with PRF at 42°C) can increase long-term efficacy (85%–92% effective rate for 1 year and 70%–92% for 2 years), while simultaneously minimizing the incidence of adverse effects [32, 36, 39], although there are some opposing opinions [20]. Nonetheless, large-scale clinical trials are needed to evaluate the effectiveness of RFT combined with PRF for the treatment of TN.

6. Improving the Effectiveness and Feasibility of RFT

Increasing the temperature is not the only effective way to improve the efficacy of RFT treatment. Regulating the distance between the tip of the needle and the target nerves is crucial. The target location should be in the junction between the third division and the trigeminal ganglion, which can effectively improve the postoperative effects [15]. In addition, three-dimensional computed tomography (CT) or neuronavigator-guided control can be used to improve the accuracy of the puncture by monitoring the direction and angle of the needle in real time [52, 53]. This technology simplifies the puncture process and avoids severe intraoperative or postoperative side effects, such as damage to the optic nerve, auditory nerve, internal carotid artery, and cavernous sinus. It is especially important to select the parameters of RFT. For example, at <0.1 V, an abnormal sensation or muscle contraction is induced in the areas controlled by the target nerves, suggesting that the needle tip is located in the nerve sheath. When RFT is performed, Aα and Aβ fibers are destroyed nonselectively, rather than just the Aб and C unmyelinated nerve fibers. Therefore, we recommended refraining from using high temperatures for RFT. If the above signs appear at 0.1–0.3 V, the needle tip should be directed to the nerve root, and the temperature should be controlled to ≤70°C. At >0.3 V, we suggest that the needle tip be at a certain distance from the nerve and be located near the ganglion. Consequently, only the small nerves (i.e., the Aб and C unmyelinated nerve fibers) will be heated, and the location of the needle tip should be adjusted to enhance efficiency [9, 37].

7. Conclusion

In summary, RF treatment is a safe, effective, and minimally invasive procedure of TN. An optimal temperature should be selected according to the branches of the trigeminal nerves involved in the RFT procedure. If V1 is involved, in order to decrease the risk of corneal reflex weakness or disappearing, a temperature of ≤65°C is recommended. If V2 and/or V3 are involved, 65–70°C temperatures are more suitable to effectively control pain and decrease the probability of adverse reactions. Too high temperature (≥80°C) should be avoided because it could seriously damage the tissue and is associated with irreversible complications. In order to improve the accuracy of the puncture and decrease the complications of injuring crucial blood vessels and nerves caused by repeated punctures, it is better to use three-dimensional CT or neuronavigator as guidance. Although the value of PRF for the treatment of TN remains controversial, RFT at ≤75°C combined with PRF is a feasible option, and further clinical trials are required to evaluate efficacy.

Conflicts of Interest

The authors declare no conflicts of interest regarding the publication of this paper.

Authors’ Contributions

All authors contributed equally to this work.

Acknowledgments

Financial support was provided by Professor Peng Yao’s Funding (no. 20170541032) from the Natural Science Foundation of Liaoning Province.

References

J. S. Koopman, J. P. Dieleman, F. J. Huygen et al., “Incidence of facial pain in the general population,” Pain, vol. 147, no. 1–3, pp. 122–127, 2009.
View at: Publisher Site | Google Scholar
J. P. Dieleman, J. Kerklaan, F. J. P. M. Huygen, P. A. D. Bouma, and M. C. J. M. Sturkenboom, “Incidence rates and treatment of neuropathic pain conditions in the general population,” Pain, vol. 137, no. 3, pp. 681–688, 2008.
View at: Publisher Site | Google Scholar
G. C. Hall, D. Carroll, D. Parry, and H. J. McQuay, “Epidemiology and treatment of neuropathic pain: the UK primary care perspective,” Pain, vol. 122, no. 1-2, pp. 156–162, 2006.
View at: Publisher Site | Google Scholar
G. Peters and T. J. Nurmikko, “Peripheral and gasserian ganglion-level procedures for the treatment of trigeminal neuralgia,” The Clinical Journal of Pain, vol. 18, no. 1, pp. 28–34, 2002.
View at: Publisher Site | Google Scholar
P. Asplund, P. Blomstedt, and A. T. Bergenheim, “Percutaneous balloon compression vs percutaneous retrogasserian glycerol rhizotomy for the primary treatment of trigeminal neuralgia,” Neurosurgery, vol. 78, no. 3, pp. 421–428, 2016.
View at: Publisher Site | Google Scholar
A. L. Ko, A. Ozpinar, A. Lee, A. M. Raslan, S. McCartney, and K. J. Burchiel, “Long-term efficacy and safety of internal neurolysis for trigeminal neuralgia without neurovascular compression,” Journal of Neurosurgery, vol. 122, no. 5, pp. 1048–1057, 2015.
View at: Publisher Site | Google Scholar
J. Régis, C. Tuleasca, N. Resseguier et al., “Long-term safety and efficacy of Gamma Knife surgery in classical trigeminal neuralgia: a 497-patient historical cohort study,” Journal of Neurosurgery, vol. 124, no. 4, pp. 1079–1087, 2016.
View at: Publisher Site | Google Scholar
H. S. Jin, J. Y. Shin, Y. C. Kim et al., “Predictive factors associated with success and failure for radiofrequency thermocoagulation in patients with trigeminal neuralgia,” Pain Physician, vol. 18, no. 6, pp. 537–545, 2015.
View at: Google Scholar
Y. Z. Tang, L. Q. Yang, J. N. Yue et al., “The optimal radiofrequency temperature in radiofrequency thermocoagulation for idiopathic trigeminal neuralgia: a cohort study,” Medicine (Baltimore), vol. 95, no. 28, p. e4103, 2016.
View at: Publisher Site | Google Scholar
D. Thapa, V. Ahuja, C. Dass, and P. Verma, “Management of refractory trigeminal neuralgia using extended duration pulsed radiofrequency application,” Pain Physician, vol. 18, no. 3, pp. E433–E435, 2015.
View at: Google Scholar
F. Luo, T. Wang, J. J. Lu, and N. Ji, “Comparison of high-voltage- with standard-voltage pulsed radiofrequency of gasserian ganglion in the treatment of idiopathic trigeminal neuralgia,” Pain Practice, vol. 15, no. 7, pp. 595–603, 2015.
View at: Publisher Site | Google Scholar
P. A. Kowacs, M. A. T. Utiumi, F. A. Nascimento, E. J. Piovesan, and H. A. G. Teive, “OnabotulinumtoxinA for trigeminal neuralgia: a review of the available data,” Arquivos de Neuro-Psiquiatria, vol. 73, no. 10, pp. 877–884, 2015.
View at: Publisher Site | Google Scholar
J. Degn and J. Brennum, “Surgical treatment of trigeminal neuralgia. Results from the use of glycerol injection, microvascular decompression, and rhizotomia,” Acta Neurochirurgica, vol. 152, no. 12, pp. 2125–2132, 2010.
View at: Publisher Site | Google Scholar
S. A. Shah, M. N. Khan, S. F. Shah, A. Ghafoor, and A. Khattak, “Is peripheral alcohol injection of value in the treatment of trigeminal neuralgia? An analysis of 100 cases,” International Journal of Oral and Maxillofacial Surgery, vol. 40, no. 4, pp. 388–392, 2011.
View at: Publisher Site | Google Scholar
M. F. Fraioli, B. Cristino, L. Moschettoni, G. Cacciotti, and C. Fraioli, “Validity of percutaneous controlled radiofrequency thermocoagulation in the treatment of isolated third division trigeminal neuralgia,” Surgical Neurology, vol. 71, no. 2, pp. 180–183, 2009.
View at: Publisher Site | Google Scholar
P. Yao, T. Hong, Z. B. Wang et al., “Treatment of bilateral idiopathic trigeminal neuralgia by radiofrequency thermocoagulation at different temperatures,” Medicine (Baltimore), vol. 95, no. 29, p. e4274, 2016.
View at: Publisher Site | Google Scholar
M. J. Teixeira, S. R. D. T. Siqueira, and G. M. Almeida, “Percutaneous radiofrequency rhizotomy and neurovascular decompression of the trigeminal nerve for the treatment of facial pain,” Arquivos de Neuro-Psiquiatria, vol. 64, no. 4, pp. 983–989, 2006.
View at: Publisher Site | Google Scholar
M. Bozkurt, E. S. M. Al-Beyati, M. Ozdemir et al., “Management of bilateral trigeminal neuralgia with trigeminal radiofrequency rhizotomy: a treatment strategy for the life-long disease,” Acta Neurochirurgica, vol. 154, no. 5, pp. 785–792, 2012.
View at: Publisher Site | Google Scholar
B. Huang, M. Yao, Z. Feng et al., “CT-guided percutaneous infrazygomatic radiofrequency neurolysis through foramen rotundum to treat V2 trigeminal neuralgia,” Pain Medicine, vol. 15, no. 8, pp. 1418–1428, 2014.
View at: Publisher Site | Google Scholar
X. Li, J. Ni, L. Yang et al., “A prospective study of Gasserian ganglion pulsed radiofrequency combined with continuous radiofrequency for the treatment of trigeminal neuralgia,” Journal of Clinical Neuroscience, vol. 19, no. 6, pp. 824–828, 2012.
View at: Publisher Site | Google Scholar
Y. Kanpolat, A. Savas, A. Bekar, and C. Berk, “Percutaneous controlled radiofrequency trigeminal rhizotomy for the treatment of idiopathic trigeminal neuralgia: 25-year experience with 1600 patients,” Neurosurgery, vol. 48, no. 3, pp. 524–534, 2001.
View at: Publisher Site | Google Scholar
J. M. Taha, J. M. Tew, and C. R. Buncher, “A prospective 15-year follow up of 154 consecutive patients with trigeminal neuralgia treated by percutaneous stereotactic radiofrequency thermal rhizotomy,” Journal of Neurosurgery, vol. 83, no. 6, pp. 989–993, 1995.
View at: Publisher Site | Google Scholar
G.-H. Lai, Y.-Z. Tang, X.-P. Wang, H.-J. Qin, and J.-X. Ni, “CT-guided percutaneous radiofrequency thermocoagulation for recurrent trigeminal neuralgia after microvascular decompression,” Medicine, vol. 94, no. 32, p. e1176, 2015.
View at: Publisher Site | Google Scholar
F. Nie, D. Su, Y. Shi et al., “A prospective study of X-ray imaging combined with skin stimulation potential-guided percutaneous radiofrequency thermocoagulation of the Gasserian ganglion for treatment of trigeminal neuralgia,” Pain Medicine, vol. 15, no. 9, pp. 1464–1469, 2014.
View at: Publisher Site | Google Scholar
W. Fouad, “Management of trigeminal neuralgia by radiofrequency thermocoagulation,” Alexandria Journal of Medicine, vol. 47, no. 1, pp. 79–86, 2011.
View at: Publisher Site | Google Scholar
T. Inoue, H. Hirai, A. Shima, F. Suzuki, T. Fukushima, and M. Matsuda, “Diagnosis and management for trigeminal neuralgia caused solely by venous compression,” Acta Neurochirurgica, vol. 159, no. 4, pp. 681–688, 2017.
View at: Publisher Site | Google Scholar
A. A. Kemeny, “Long-term outcomes of microvascular decompression and Gamma Knife surgery for trigeminal neuralgia: a retrospective comparison study,” Acta Neurochirurgica, vol. 159, no. 11, p. 2137, 2017.
View at: Publisher Site | Google Scholar
Q. Wan, D. Zhang, X. Cao, Y. Zhang, M. Zhu, and W. Zuo, “CT-guided selective percutaneous radiofrequency thermocoagulation via the foramen rotundum for isolated maxillary nerve idiopathic trigeminal neuralgia,” Journal of Neurosurgery, vol. 128, no. 1, pp. 211–214, 2018.
View at: Publisher Site | Google Scholar
Y. Li, L. Yang, J. Ni, and Z. Dou, “Microvascular decompression and radiofrequency for the treatment of trigeminal neuralgia: a meta-analysis,” Journal of Pain Research, vol. 12, pp. 1937–1945, 2019.
View at: Publisher Site | Google Scholar
S. Kosugi, M. Shiotani, Y. Otsuka et al., “Long-term outcomes of percutaneous radiofrequency thermocoagulation of gasserian ganglion for 2nd- and multiple-division trigeminal neuralgia,” Pain Practice, vol. 15, no. 3, pp. 223–228, 2015.
View at: Publisher Site | Google Scholar
H. P. Smith, J. M. McWhorter, and V. R. Challa, “Radiofrequency neurolysis in a clinical model. Neuropathological correlation,” Journal of Neurosurgery, vol. 55, no. 2, pp. 246–253, 1981.
View at: Publisher Site | Google Scholar
W.-X. Zhao, Q. Wang, M.-W. He, L.-Q. Yang, B.-S. Wu, and J.-X. Ni, “Radiofrequency thermocoagulation combined with pulsed radiofrequency helps relieve postoperative complications of trigeminal neuralgia,” Genetics and Molecular Research, vol. 14, no. 3, pp. 7616–7623, 2015.
View at: Publisher Site | Google Scholar
B. C. Son, H. S. Kim, I.-S. Kim et al., “Percutaneous radiofrequency thermocoagulation under fluoroscopic image-guidance for idiopathic trigeminal neuralgia,” Journal of Korean Neurosurgical Society, vol. 50, no. 5, pp. 446–452, 2011.
View at: Publisher Site | Google Scholar
P. Yao, Y.-y. Deng, T. Hong et al., “Radiofrequency thermocoagulation for V2/V3 idiopathic trigeminal neuralgia,” Medicine, vol. 95, no. 26, p. e4019, 2016.
View at: Publisher Site | Google Scholar
J. T. Yang, M. Lin, M. H. Lee et al., “Percutaneous trigeminal nerve radiofrequency rhizotomy guided by computerized tomography with three-dimensional image reconstruction,” Chang Gung Medical Journal, vol. 33, no. 6, pp. 679–683, 2010.
View at: Google Scholar
P. Yao, T. Hong, Y.-q. Zhu et al., “Efficacy and safety of continuous radiofrequency thermocoagulation plus pulsed radiofrequency for treatment of V1 trigeminal neuralgia,” Medicine, vol. 95, no. 44, p. e5247, 2016.
View at: Publisher Site | Google Scholar
M. V. Koning, N. J. Koning, H. M. Koning, and M. van Kleef, “Relationship between sensory stimulation and side effects in percutaneous radiofrequency treatment of the trigeminal ganglion,” Pain Practice, vol. 14, no. 7, pp. 581–587, 2014.
View at: Publisher Site | Google Scholar
Q. D. Huang, X. M. Liu, J. S. Chen et al., “The effectiveness and safety of thermocoagulation radiofrequency treatment of the ophthalmic division (V1) and/or maxillary (V2) and mandibular (V3) division in idiopathic trigeminal neuralgia: an observational study,” Pain Physician, vol. 19, no. 7, pp. E1041–E1047, 2016.
View at: Google Scholar
A. Elawamy, E. E. M. Abdalla, and G. A. Shehata, “Effects of pulsed versus conventional versus combined radiofrequency for the treatment of trigeminal neuralgia: a prospective study,” Pain Physician, vol. 20, no. 6, pp. E873–E881, 2017.
View at: Google Scholar
S. Erdine, N. S. Ozyalcin, A. Cimen, M. Celik, G. K. Talu, and R. Disci, “Comparison of pulsed radiofrequency with conventional radiofrequency in the treatment of idiopathic trigeminal neuralgia,” European Journal of Pain, vol. 11, no. 3, pp. 309–313, 2007.
View at: Publisher Site | Google Scholar
S. Zheng, B. Wu, Y. Zhao et al., “Masticatory muscles dysfunction after CT-guided percutaneous trigeminal radiofrequency thermocoagulation for trigeminal neuralgia: a detailed analysis,” Pain Practice, vol. 15, no. 8, pp. 712–719, 2015.
View at: Publisher Site | Google Scholar
P. Liu, W. Zhong, C. Liao, M. Yang, and W. Zhang, “The role of percutaneous radiofrequency thermocoagulation for persistent or recurrent trigeminal neuralgia after surgery,” Journal of Craniofacial Surgery, vol. 27, no. 8, pp. e752–e755, 2016.
View at: Publisher Site | Google Scholar
F. C. Vinas, L. Zamorano, M. Dujovny et al., “In vivo and in vitro study of the lesions produced with a computerized radiofrequency system,” Stereotactic and Functional Neurosurgery, vol. 58, no. 1–4, pp. 121–133, 1992.
View at: Publisher Site | Google Scholar
H. V. I. Easwer, N. Chatterjee, A. Thomas, K. Santhosh, K. T. Raman, and R. Sridhar, “Usefulness of flat detector CT (FD-CT) with biplane fluoroscopy for complication avoidance during radiofrequency thermal rhizotomy for trigeminal neuralgia,” Journal of NeuroInterventional Surgery, vol. 8, no. 8, pp. 830–833, 2016.
View at: Publisher Site | Google Scholar
M. E. Sluijter, A. Teixeira, V. Serra, S. Balogh, and P. Schianchi, “Intra-articular application of pulsed radiofrequency for arthrogenic pain-report of six cases,” Pain Practice, vol. 8, no. 1, pp. 57–61, 2008.
View at: Publisher Site | Google Scholar
J. V. Zundert, S. Brabant, E. V. de Kelft, A. Vercruyssen, and J.-P. V. Buyten, “Pulsed radiofrequency treatment of the gasserian ganglion in patients with idiopathic trigeminal neuralgia,” Pain, vol. 104, no. 3, pp. 449–452, 2003.
View at: Publisher Site | Google Scholar
J. H. Kim, H. Y. Yu, S. Y. Park, S. C. Lee, and Y. C. Kim, “Pulsed and conventional radiofrequency treatment: which is effective for dental procedure-related symptomatic trigeminal neuralgia?” Pain Medicine, vol. 14, no. 3, pp. 430–435, 2013.
View at: Publisher Site | Google Scholar
F. Luo, Y. Shen, T. Wang et al., “3D CT guided pulsed radiofrequency treatment for trigeminal neuralgia,” Pain Practice, vol. 14, no. 1, pp. 16–21, 2014.
View at: Publisher Site | Google Scholar
T. Arıcı, M. Kurcaloğlu, E. Kılıç, and E. Erhan, “Radiofrequency thermocoagulation combined with pulsed radiofrequency for gasserian ganglion blockage,” Agri, vol. 30, no. 4, pp. 179–182, 2018.
View at: Publisher Site | Google Scholar
F. Luo, L. Meng, T. Wang, X. Yu, Y. Shen, and N. Ji, “Pulsed radiofrequency treatment for idiopathic trigeminal neuralgia: a retrospective analysis of the causes for ineffective pain relief,” European Journal of Pain, vol. 17, no. 8, pp. 1189–1192, 2013.
View at: Publisher Site | Google Scholar
N. H. L. Chua, W. Halim, T. Beems, and K. C. Vissers, “Pulsed radiofrequency treatment for trigeminal neuralgia,” Anesthesiology and Pain Medicine, vol. 1, no. 4, pp. 257–261, 2012.
View at: Publisher Site | Google Scholar
S.-j. Xu, W.-h. Zhang, T. Chen, C.-y. Wu, and M.-d. Zhou, “Neuronavigator-guided percutaneous radiofrequency thermocoagulation in the treatment of intractable trigeminal neuralgia,” Chinese Medical Journal, vol. 119, no. 18, pp. 1528–1535, 2006.
View at: Publisher Site | Google Scholar
N. Wang and Y. S. Hu, “Clinical efficacy of the combination of neuronavigation and electrophysyological monitoring techniques percutaneous radiofrequency thermocoagulation therapy for the treatment of trigeminal neuralgia,” Chinese Journal of Pain Medicine, vol. 22, no. 11, pp. 823–827, 2016.
View at: Google Scholar

Copyright

Copyright © 2020 Tao Hong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

6405

Downloads

1668

Citations